Fumiaki Kato
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cell Tracking Suggests Pathophysiological and Therapeutic Role of Bone Marrow Cells in Sugen5416/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Journal: The Canadian journal of cardiology
Published: July 11, 2020
Direct Experimental Evidence for Markedly Enhanced Surface Proton Activity Inherent to Water Ice.
Journal: The journal of physical chemistry letters
Published: March 10, 2020
Thickness dependent homogeneous crystallization of ultrathin amorphous solid water films.
Journal: Physical chemistry chemical physics : PCCP
Published: January 16, 2020
Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension.
Journal: International journal of cardiology
Published: March 02, 2019
Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 16, 2018
The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study.
Journal: Pulmonary circulation
Published: June 13, 2017
Repeated Diffuse Alveolar Hemorrhage in a Patient with Hemophilia B.
Journal: Internal medicine (Tokyo, Japan)
Published: February 17, 2017
Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: November 28, 2016
Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor.
Journal: Respiratory investigation
Published: October 03, 2016
Pulmonary haemodynamics are correlated with intimal lesions in a rat model of severe PAH: attenuation of pulmonary vascular remodelling with ambrisentan.
Journal: Histology and histopathology
Published: April 07, 2016
Last Updated: 09/26/2026